"Promising Experimental Drug Shows Potential in Countering Space-induced Bone Loss"

Scientists have developed an experimental treatment that promotes bone growth in mice living aboard the International Space Station (ISS) for at least nine weeks, potentially mitigating the bone loss experienced by astronauts in space. The treatment combines a molecule called NELL-1 with bisphosphonate, a drug used to prevent bone loss. The researchers are excited about the implications of their findings for future space exploration and potential medical applications on Earth. Further research is needed to validate the treatment's long-term safety and effectiveness.